Health and Fitness Health and Fitness
Wed, June 6, 2012
Tue, June 5, 2012
Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan

Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html
Published in Health and Fitness on Wednesday, May 30th 2012 at 7:40 GMT by Market Wire   Print publication without navigation


Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference -- AUSTIN, Texas, May 30, 2012 /PRNewswire/ --

Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference

[ ]

AUSTIN, Texas, May 30, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: [ LMNX ]) today announced that management will present at the Jefferies 2012 Global Healthcare Conference to be held June 4-7 in New York.

(Logo:  [ http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ])

The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:30 p.m. Eastern time on Wednesday, June 6, 2012.  The presentation will be webcast live and may be accessed at Luminex Corporation's website at [ http://www.luminexcorp.com ].  Simply log on to the website, go to the About Us section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at [ http://www.luminexcorp.com ].

Contacts:  

Harriss T. Currie


Vice President, Finance and Chief Financial Officer


512-219-8020






Matthew Scalo


Sr. Director of Investor Relations


512-219-8020


[ mscalo@luminexcorp.com ]

SOURCE Luminex Corporation

[ Back to top ]

RELATED LINKS
[ http://www.luminexcorp.com ]


Publication Contributing Sources